XML 88 R77.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT REPORTING - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting Information [Line Items]        
Total revenues $ 86,106 $ 84,700 $ 259,043 $ 254,416
Cost of revenues (excluding amortization and depreciation and stock compensation expense) 42,048 42,369 122,831 127,472
Product development (excluding stock compensation) 8,171 7,735 24,530 26,629
Sales and marketing (excluding stock compensation) 5,673 5,944 19,123 20,351
General and administrative expenses (excluding stock compensation) 19,416 19,376 56,957 57,651
Total expenses 82,038 81,886 243,188 254,340
Total Adjusted EBITDA 16,272 14,692 48,245 38,460
Operating Segments        
Segment Reporting Information [Line Items]        
Total expenses 69,834 70,008 210,798 215,956
Financial Health        
Segment Reporting Information [Line Items]        
Total revenues 54,501 54,672 164,918 162,620
Cost of revenues (excluding amortization and depreciation and stock compensation expense) 29,335 29,185 85,835 89,051
Financial Health | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 54,501 54,672 164,918 162,620
Cost of revenues (excluding amortization and depreciation and stock compensation expense) 29,208 29,077 85,123 88,762
Product development (excluding stock compensation) 3,249 1,888 9,360 6,219
Sales and marketing (excluding stock compensation) 3,466 3,664 12,326 12,959
General and administrative expenses (excluding stock compensation) 9,706 10,079 30,865 29,710
Total expenses 45,629 44,708 137,674 137,650
Total Adjusted EBITDA 8,872 9,964 27,244 24,970
Patient Care        
Segment Reporting Information [Line Items]        
Total revenues 31,605 30,028 94,125 91,796
Cost of revenues (excluding amortization and depreciation and stock compensation expense) 12,713 13,184 36,996 38,421
Patient Care | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 31,605 30,028 94,125 91,796
Cost of revenues (excluding amortization and depreciation and stock compensation expense) 12,538 13,069 36,569 38,220
Product development (excluding stock compensation) 4,676 5,616 14,474 19,712
Sales and marketing (excluding stock compensation) 1,990 2,067 6,169 6,830
General and administrative expenses (excluding stock compensation) 5,001 4,548 15,912 13,544
Total expenses 24,205 25,300 73,124 78,306
Total Adjusted EBITDA $ 7,400 $ 4,728 $ 21,001 $ 13,490